Sulfotransferase-Mediated Activation of Some Benzylic and Allylic Alcohols

  • Young-Joon Surh
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 387)


Sulfo-conjugation in general renders the lipophilic xenobiotics water-soluble, thereby facilitating their removal from the body through excretion in urine or bile. Under certain circumstances, however, sulfonation can also contribute to toxification of some classes of chemicals (recently reviewed by Miller, 1994; Miller and Surh, 1994). Since the first discovery of 2-acetylaminofluorene-N-sulfate as an electrophilic metabolite of N-hydroxy-2-acetylaminofluorene (Debaun et al., 1968; King and Phillips, 1968), there has been accumulated evidence for the association between sulfonation and induction of tumors by this carcinogen and others. Although the “bay-region” theory is widely accepted as a general concept in determining the tumorigenicity of polycyclic aromatic compounds (PAH) in general, recent studies have shown that PAHs bearing benzylic hydroxyl functional groups can also be activated via sulfuric acid esterification (vide infra). This report briefly reviews our recent findings on metabolic activation of some benzylic alcohols to electrophilic, mutagenic, or carcinogenic sulfate esters. The paper also concerns the sulfate ester of the heterocyclic allylic alcohol, 5-hydroxymethylfurfural, as a novel example of electrophilic species formed by sulfotransferase activity.


Benzylic Alcohol Sulfate Ester Maillard Reaction Product Bacterial Mutagenicity Allylic Alcohol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. DeBaun, J.R., Rowley, J.Y., Miller, E.C. and Miller, J.A. (1968). Sulfotransferase-activation of N-hydroxy-2-acetylaminofluorene in rodent livers susceptible and resistant to this carcinogen. Proc. Soc. Exp. Biol. Med., 129, 268–273.PubMedCrossRefGoogle Scholar
  2. Falany, C.N., Wheeler, J., Coward, L., Keehan, D., Falany, J.L. and Barnes, S. (1992). Bioactivation of 7-hydroxymethyl-12-methylbenz[a]anthracene by rat liver bile acid sulfotransferase I. J. Biochem. Toxicol., 7, 241–248.PubMedCrossRefGoogle Scholar
  3. Glatt, H.R., Henschler, R., Phillips, D.H., Blake, J.W., Steinberg, P., Seidel, A. and Oesch, F. (1990). Sulfotransferase-mediated chlorination of 1-hydroxymethylpyrene to a mutagen capable of penetrating indicator cells. Environ. Hlth. Perspect., 88, 43–48.CrossRefGoogle Scholar
  4. Glatt, H.R., Henschler, R., Frank, H., Seidel, A., Yang, C, Abu-Shqara, E. and Harvey, R.G. (1993). Sulfotransferase-mediated mutagenicity of 1-hydroxymethylpyrene and 4H-cyclopenta[def]chrysen-4-ol and its enhancement by chloride anions. Carcinogenesis, 14, 599–602.PubMedCrossRefGoogle Scholar
  5. Glatt, H.R., Werle-Schneider, G., Enders, N., Monnerjahan, S., Pudil, J., Czich, A., Seidel, A. and Schwarz, M. (1994a). 1-Hydroxymethylpyrene and its sulfuric acid ester: toxicological effects in vitro and in vivo, and metabolic aspects. Chem.-Biol. Interact., 92, 305–319.PubMedCrossRefGoogle Scholar
  6. Glatt, H., Pauly, K., Frank, H., Seidel, A., Oesch, F., Harvey, R.G. and Werle-Schneider, G. (1994b). Substrate-dependent sex differences in the activation of benzylic alcohols to mutagens by hepatic sulfotransferases of the rat. Carcinogenesis, 15, 2605–2611.PubMedCrossRefGoogle Scholar
  7. King, C.M. and Phillips, B. (1968). Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid. Science, 159, 1351–1353.PubMedCrossRefGoogle Scholar
  8. Lee, Y.-C., Shlyankevich, M. and Surh, Y.-J. (1995). Sulfotransferase-mediated activation of 5-hydroxymethylfurfural to a mutagen. Proc. Am. Assoc. Cancer Res., 36, in press.Google Scholar
  9. Maron, D.M. and Ames, B.R (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 290, 111–118.Google Scholar
  10. Miller, J.A. (1994). Sulfonation in chemical carcinogenesis-history and present status. Chem.-Biol. Interact., 92, 329–341.PubMedCrossRefGoogle Scholar
  11. Miller, J.A. and Surh, Y.-J. (1994). Sulfonation in chemical carcinogenesis. In Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (F.C. Kauffman Ed.), pp. 459–509. Springer-Verlag, Heidelberg.Google Scholar
  12. Omura, H., Jahan, N., Shinohara, K. and Murakami, H. (1983). Formation of mutagens by the Maillard reaction. In The Maillard reaction in Foods and Nutrition (G.R. Waller and M.S. Feather, Eds.), pp. 537–563, American Chemical Society, Washington, D.C.CrossRefGoogle Scholar
  13. Schoental, R., Hard, G.C. and Gibbard, S. (1971). Histopathology of renal lipomatous tumours in rats treated with the natural products, pyrrolizidine alkaloids and alpha, beta-unsaturated aldehydes. I. J. Natl Cancer Inst., 47, 1037–1044.Google Scholar
  14. Surh, Y.-J., Lai, C.-C, Miller, J.A. and Miller, E.C. (1987). Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methylbenz[a] anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice. Biochem. Biophys. Res. Commun., 144, 576–582.PubMedCrossRefGoogle Scholar
  15. Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1989). Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Carcinogenesis, 10, 1519–1528.PubMedCrossRefGoogle Scholar
  16. Surh, Y.-J., Blomquist, J.C., Liem, A. and Miller, J.A. (1990a). Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic, and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Carcinogenesis, 11: 1451–1460.PubMedCrossRefGoogle Scholar
  17. Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1990b). The strong hepatocarcinogenicity of the electrophilic and mutagenic metabolite 6-sulfooxymethylbenzo[a]pyrene and its formation of benzylic DNA adducts in the livers of infant male B6C3F1 mice. Biochem. Biophys. Res. Commun., 172, 85–91.PubMedCrossRefGoogle Scholar
  18. Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1991a). Age-and sex-related differences in activation of the carcinogen, 7-hydroxymethyl-12-methylbenz[a]anthracene to an electrophilic sulfuric acid ester metabolite in rats: possible involvement of hydroxysteroid sulfotransferase activity. Biochem. Pharmacol., 41, 213–221.PubMedCrossRefGoogle Scholar
  19. Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1991b). Activation and detoxication of 6-hydroxymethylbenzo[a]pyrene via its electrophilic and carcinogenic sulfuric acid ester metabolite. Proc. Am. Assoc. Cancer Res., 32, 726.Google Scholar
  20. Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1991c). 7-Sulfooxymethyl-12-methyl-benz[a]anthracene is an electrophilic mutagen, but does not appear to play a role in carcinogenesis by 7, 12-dimethylbenz[a]anthracene or 7-hydroxymethyl-12-methyl-benz[a]anthracene. Carcinogenesis, 12, 339–347.PubMedCrossRefGoogle Scholar
  21. Surh, Y.-J., Blomquist, J.C. and Miller, J.A. (1991d). Activation of 1-hydroxymethyl-pyrene to an electrophilic and mutagenic metabolite by rat hepatic sulfotransferase activity. Adv. Exp. Med. Biol, 283, 383–391.PubMedCrossRefGoogle Scholar
  22. Surh, Y.-J., Kwon, H. and Tannenbaum, S.R. (1993). Sulfotransferase-mediated activation of 4-hydroxy-and 3,4-dihydroxy-3,4-dihydrocyclopenta[cd]pyrene, the major secondary metabolites of cyclopenta[cd]pyrene. Cancer Res., 53, 1017–1022.PubMedGoogle Scholar
  23. Surh, Y.-J. and Miller, J.A. (1994). Roles of electrophilic sulfuric acid ester metabolites in mutagenesis and carcinogenesis by some polynuclear aromatic hydrocarbons. Chem.-Biol. Interact., 92, 351–362.PubMedCrossRefGoogle Scholar
  24. Surh, Y.-J. and Tannenbaum, S.R. (1994a). Bioactivation of cyclopenta-and cyclohexa-fused polycyclic aromatic hydrocarbons via the formation of benzylic sulfuric acid esters. Polycyclic Aromatic Compounds., 7, 83–90.CrossRefGoogle Scholar
  25. Surh, Y.-J. and Tannenbaum, S.R. (1994b). Activation of the Maillard reaction product, 5-hydroxymethylfurfural via allylic sulfonation and chlorination. Chem. Res. Toxicol, 7, 313–318.PubMedCrossRefGoogle Scholar
  26. Surh, Y.-J., Park, K. K., and Miller, J.A. (1994a). Inhibitory effect of vitamin C on the mutagenicity and covalent DNA binding of the electrophilic and carcinogenic metabolite, 6-sulfooxymethylbenzo[a]pyrene. Carcinogenesis, 15, 917–920.PubMedCrossRefGoogle Scholar
  27. Surh, Y.-J., Liem. A., Miller, J.A. and Tannenbaum, S.R. (1994b). 5-Sulfooxymethylfurfural as a possible ultimate mutagenic and carcinogenic metabolite of the Maillard reaction product, 5-hydroxymethylfurfural. Carcinogenesis, 15, 2375–2377.PubMedCrossRefGoogle Scholar
  28. Ulbricht, R.J., Northup, S.J. and Thomas, J.A. (1984). A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions. Fund. Appl. Toxicol, 4, 843–853.CrossRefGoogle Scholar
  29. Watabe, T., Hiratsuka, A. and Ogura, K. (1987). Sulfotransferase-mediated covalent binding of the carcinogen 7,12-dihydroxymethylbenz[a]anthracene to calf thymus DNA and its inhibition by glutathione transferase. Carcinogenesis, 8, 445–453.PubMedCrossRefGoogle Scholar
  30. Watabe, T., Ogura, K., Okuda, H. and Hiraszuka, A. (1989). Hydroxymethyl sulfate esters as reactive metabolites of the carcinogens, 7-methyl-and 7,12-dihydroxymethyl-benz[a]anthracenes and 5-methylchrysene. In Xenobiotic Metabolism and Disposition (R. Kato, R.W. Estabrook and M.N. Cayen, Eds.), pp. 393–400. Taylor and Francis, London.Google Scholar
  31. Zhang, X.-M., Chan, C.C., Stamp, D., Minkin, S., Archer, M.C. and Bruce, W.R. (1993). Initiation and promotion of colonic aberrant crypt foci in rats by 5-hydroxymethyl-2-furaldehyde in thermolyzed sucrose. Carcinogenesis, 14, 773–775.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Young-Joon Surh
    • 1
  1. 1.Division of Environmental Health Sciences Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations